LUPIN LTD Company Profile

✉ Email this page to a colleague

LUPIN LTD has one hundred and fifty-eight approved drugs.

There is one US patent protecting LUPIN LTD drugs. There are nineteen tentative approvals on LUPIN LTD drugs.

There are two patent family members on LUPIN LTD drugs in two countries and five hundred and eighty-three supplementary protection certificates in seventeen countries.

International Patents:	2
US Patents:	1
Tradenames:	137
Ingredients:	120
NDAs:	158
Drug Master File Entries:	194
Patent Litigation for LUPIN LTD:	See patent lawsuits for LUPIN LTD
PTAB Cases with LUPIN LTD as petitioner:	See PTAB cases with LUPIN LTD as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin Ltd	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	200797-002	Jun 3, 2015	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lupin Ltd	DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM	drospirenone; ethinyl estradiol; levomefolate calcium	TABLET;ORAL	205947-001	Jun 13, 2018	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lupin Ltd	BEKYREE	desogestrel; ethinyl estradiol	TABLET;ORAL-28	202226-001	Aug 12, 2015	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lupin Ltd	PAROXETINE HYDROCHLORIDE	paroxetine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	204134-002	Jan 20, 2017	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Lupin Ltd	ARMODAFINIL	armodafinil	TABLET;ORAL	200751-001	Nov 28, 2016	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30
➤ Subscribe	for Oral Suspension	500 mg/5 mL	➤ Subscribe	2014-07-22

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Germany	112007000920	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2007119249	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1419152	132012902054377	Italy	⤷ Try a Trial	PRODUCT NAME: EMTRICITABINA/RILPIVIRINA CLORIDRATO/TENOFOVIR DISOPROXIL FUMARATO(EVIPLERA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/11/737/001-002, 20111128
0582455	08C0021	France	⤷ Try a Trial	PRODUCT NAME: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE; REGISTRATION NO/DATE: EU/1/07/430/001 20071213
0740668	C00740668/01	Switzerland	⤷ Try a Trial	PRODUCT NAME: TADALAFILUM; REGISTRATION NUMBER/DATE: SWISSMEDIC 56018 04.05.2004
1632232	122016000111	Germany	⤷ Try a Trial	PRODUCT NAME: KOMBINATION VON RILPIVIRINHYDROCHLORID ODER EINER THERAPEUTISCH AEQUIVALENTEN, DURCH DAS GRUNDPATENT GESCHUETZTEN FORM DAVON, EMTRICITABIN UND TENOFOVIRALAFENAMID ODER EINEM PHARMAZEUTISCH AKZEPTABLEN SALZ DAVON, INSBESONDERE TENOFOVIRALAFENAMIDFUMARAT; REGISTRATION NO/DATE: EU/1/16/1112 20160621
2487166	59/2016	Austria	⤷ Try a Trial	PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND TENOFOVIR ALAFENAMID ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE TENOFOVIR ALAFENAMID FUMARAT; REGISTRATION NO/DATE: EU/1/15/1061 (MITTEILUNG) 20151123
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.